Suppr超能文献

G2P[4] 株病毒演变动力学与轮状病毒疫苗接种:Rotarix 的相关证据综述。

Dynamics of G2P[4] strain evolution and rotavirus vaccination: A review of evidence for Rotarix.

机构信息

GSK, 23 Rochester Park, Singapore 139234, Singapore.

GSK, Av. Fleming 20, 1300 Wavre, Belgium.

出版信息

Vaccine. 2020 Jul 31;38(35):5591-5600. doi: 10.1016/j.vaccine.2020.06.059. Epub 2020 Jul 7.

Abstract

Rotavirus (RV) gastroenteritis is a vaccine-preventable disease that creates high medical and economic burden in both developed and developing countries. Worldwide, more than 100 countries have introduced RV vaccines in their national immunization programs, and the remarkable impact of reducing the burden of severe childhood gastroenteritis has been unequivocally demonstrated. Currently, 2 oral vaccines (Rotarix, GSK and RotaTeq, Merck) are widely utilized. Recent temporary increases in the relative prevalence of G2P[4] RV strains have been observed in countries implementing RV vaccination. This comprehensive literature review aims to provide an insight on RV genotype evolution in the context of mass vaccination with Rotarix, particularly in the case of G2P[4]. In the post-vaccine era, strain surveillance data indicated temporal and spatial changes in countries both with and without RV vaccination programs. Annual fluctuations in G2P[4] prevalence seem to occur naturally, with no substantial differences between countries using Rotarix, RotaTeq or mixed vaccination programs. Moreover, Rotarix has been shown to be efficacious and effective against gastroenteritis caused by non-vaccine strains, including G2P[4]. These data indicate that shifts in RV genotype distribution are likely to constitute an inherent process of virus evolution to infect the human gut. Following RV vaccine introduction, incidences of RV gastroenteritis declined dramatically and mass vaccination will likely maintain this status, despite possible fluctuations in the relative distribution of genotypes. There is no conclusive evidence of unusual burst of new or vaccine-escape strains since global RV vaccines use. The emergence of strains with a potential to increase the current burden of RV disease should be continuously monitored and can only be established by exhaustive characterization of strains, including whole genomic sequencing. Given the natural fluctuations in RV strains over time, caution is advised when interpreting temporal changes in RV strain dynamics, as they could mistakenly be attributed to vaccination.

摘要

轮状病毒(RV)胃肠炎是一种可通过疫苗预防的疾病,在发达国家和发展中国家都造成了沉重的医疗和经济负担。在全球范围内,已有 100 多个国家在国家免疫规划中引入了 RV 疫苗,其显著减轻严重儿童胃肠炎负担的效果得到了明确证实。目前,有 2 种口服疫苗(Rotarix、GSK 和 RotaTeq、Merck)广泛应用。在实施 RV 疫苗接种的国家,近期观察到 G2P[4]RV 株相对流行率暂时增加。本综述旨在提供有关大规模接种 Rotarix 情况下 RV 基因型演变的深入了解,特别是 G2P[4]的情况。在疫苗接种后时代,有 RV 疫苗接种计划和无 RV 疫苗接种计划的国家的监测数据均表明了病毒株的时空变化。G2P[4]流行率的年度波动似乎是自然发生的,使用 Rotarix、RotaTeq 或混合疫苗接种方案的国家之间没有实质性差异。此外,Rotarix 已被证明对非疫苗株引起的胃肠炎有效,包括 G2P[4]。这些数据表明,RV 基因型分布的变化可能构成病毒感染肠道的固有进化过程。在 RV 疫苗引入后,RV 胃肠炎的发病率急剧下降,大规模疫苗接种可能会维持这种状态,尽管基因型的相对分布可能会出现波动。自全球 RV 疫苗使用以来,尚无新的或逃避疫苗的毒株异常爆发的确凿证据。具有增加当前 RV 疾病负担潜力的毒株的出现应持续监测,并只能通过对包括全基因组测序在内的菌株进行详尽特征描述来确定。鉴于 RV 株随时间的自然波动,在解释 RV 株动力学的时间变化时需谨慎,因为这些变化可能会被错误地归因于疫苗接种。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验